These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19115422)

  • 1. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.
    Ding W; Mouzaki M; You H; Laird JC; Mato J; Lu SC; Rountree CB
    Hepatology; 2009 Apr; 49(4):1277-86. PubMed ID: 19115422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.
    Rountree CB; Senadheera S; Mato JM; Crooks GM; Lu SC
    Hepatology; 2008 Apr; 47(4):1288-97. PubMed ID: 18167064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
    Rountree CB; Ding W; He L; Stiles B
    Stem Cells; 2009 Feb; 27(2):290-9. PubMed ID: 19008348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.
    Martin M; Ancey PB; Cros MP; Durand G; Le Calvez-Kelm F; Hernandez-Vargas H; Herceg Z
    BMC Genomics; 2014 Jun; 15(1):435. PubMed ID: 24898317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and analysis of CD133(+) melanoma stem-like cells conferring resistance to taxol: An insight into the mechanisms of their resistance and response.
    El-Khattouti A; Selimovic D; Haïkel Y; Megahed M; Gomez CR; Hassan M
    Cancer Lett; 2014 Feb; 343(1):123-33. PubMed ID: 24080340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
    PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.
    Mavila N; James D; Utley S; Cu N; Coblens O; Mak K; Rountree CB; Kahn M; Wang KS
    PLoS One; 2012; 7(11):e50401. PubMed ID: 23308088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.
    Lin L; Amin R; Gallicano GI; Glasgow E; Jogunoori W; Jessup JM; Zasloff M; Marshall JL; Shetty K; Johnson L; Mishra L; He AR
    Oncogene; 2009 Feb; 28(7):961-72. PubMed ID: 19137011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
    Chen WC; Chang YS; Hsu HP; Yen MC; Huang HL; Cho CY; Wang CY; Weng TY; Lai PT; Chen CS; Lin YJ; Lai MD
    Oncotarget; 2015 Dec; 6(40):42923-37. PubMed ID: 26556861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
    Ding W; You H; Dang H; LeBlanc F; Galicia V; Lu SC; Stiles B; Rountree CB
    Hepatology; 2010 Sep; 52(3):945-53. PubMed ID: 20564331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
    Chen L; Zeng Y; Yang H; Lee TD; French SW; Corrales FJ; García-Trevijano ER; Avila MA; Mato JM; Lu SC
    FASEB J; 2004 May; 18(7):914-6. PubMed ID: 15033934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.
    You H; Ding W; Rountree CB
    Hepatology; 2010 May; 51(5):1635-44. PubMed ID: 20196115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.